Here's a summary of the Reckitt contract win - and it just happens to be Havas who TMW will be working alongside..... :o)) Coincidence? Perhaps not.... http://www.thedrum.com/news/2013/04/19/reckitt-benckiser-uk-consolodates-digital-advertising-activity-tmw "19 April 2013 - 10:14am | posted by Stephen Lepitak | 0 comments Reckitt Benckiser UK consolodates digital advertising activity into TMW Reckitt Benckiser UK, one of Britain’s largest advertisers has appointed TMW to handle its digital advertising activity across its brand portfolio, including Finish, Vanish, Dettol and Nurofen. The appointment will see TMW work alongside Havas Worldwide as Reckit Benckiser consolidates its digital advertising activity. Jerome Lemaire, UK marketing director for Reckitt Benckiser commented: “As one of the UK’s major advertisers with some of the country’s best known brands, digital has become an increasingly important part of the overall marketing mix. Up to now we have used a variety of digital agencies across the brands and while this has resulted in the creation of some memorable and effective campaigns we felt the time was right to bring in one agency who could give us consistency across the portfolio.” He added that the appointment of TMW did not affect the position of Havas Worldwide as its lead agency in the UK."
22 Apr '13
Good trading statement out today
The year end trading statement is out and is pretty good: http://www.investegate.co.uk/creston-plc--cre-/rns/trading-statement/201304220700078378C/ - core trading is in line with expectations, i.e probably 10-5p-11p EPS - net cash is over £10m! This against a £51m m/cap.... - the UK Government appointment more than offsets the Sanofi client loss in the USA, since this will now become a top 5 client - new acquisition is performing well - Insight division recovering nicely Overall then, CRE looks cheap at this level imho.
25 Mar '13
Tipped as takeover target
CRE get tipped as a prime takeover target. Interesting that he posits this purely on the basis of the fundamentals, with no mention of the Havas stake :o)) http://www.whatinvestment.co.uk/financial-news/shares-and-trading/2242483/fidelity-touts-three-takeover-targets.thtml "Fidelity touts three takeover targets Rob St George 18 Mar 2013 | News - Comment now" "Alex Wright, manager of the Fidelity UK Smaller Companies fund, opted for Creston (LON:CRE). This small-cap advertising agency boasts the merit of value: its shares trade on a forward price-to-earnings ratio of 3.6, which Wright described as ‘extraordinarily cheap’. He added: ‘It has strong positions in attractive niches such as social media and healthcare marketing, and as such could be seen as an attractive acquisition target for larger marketing and media groups.’"
4 Feb '13
During the period Creston scored a new social media account for Durex, the division's first Reckitt Benckiser brand. The group also achieved a partnership with Danacol, part of Danone, for a customer relationship management programme across France and Portugal and with EE and T-Mobile, the corporate and consumer public relations for Orange. In the company's health division, revenue and headline PBIT rose, thanks to the successful acquisition of The Corkery Group and DJM Digital Solutions. The Insight unit experienced a fall in revenues but a small headline PBIT increase as a result of the management action taken earlier in the year. "While we remain cautious in light of the macro-environment and on-going market volatility, the group is pleased with the integration of its latest acquisition, DJM Digital Solutions, and the number of new business opportunities it continues to see and convert across the wider business."
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.